Search Results 1921-1930 of 19680 for hemoglobin

1. Neurology - Clinical trials - Mayo Clinic

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

2. Neurology - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

3. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   Hemoglobin <10.0 g/dL or hematocrit <30%;; Platelet count of <150 x 109/L (<150,000/mm3);; Absolute lymphocyte count of <0.50 x 109 /L (<500/mm3);; Estimated ...

4. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

   Hemoglobin: ≥ 8.5 g/dL; White blood cells (WBC): > 3.5 x 103/μL; Neutrophils: >1.5 x 103/μL; Platelets: > 100 x 103/μL; Serum creatinine: < 1.7 mg/dL ...

5. Sonocloud-9 In Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU Or TMZ) In Recurrent GBM - Mayo Clinic

   Hemoglobin ≥ 10 g/dL, platelets ≥ 100,000/mm3, neutrophils ≥ 1500/mm3. 2. Liver function test with ≤ grade 1 alterations, except if due to antiepileptic ...

6. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

   - Hemoglobin ≥ 8 g/dL(transfusions allowed; however, patient must not be transfusion-dependent). 8. Has adequate hepatic function, including: - Total ...

7. A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy - Mayo Clinic

   Hemoglobin ≥ 0 g/dL;; Serum creatinine ≤ 1.5 xp peur limit of normal (ULN) or calculated creatinine clearance ≥ 60 mL/min using hte Cockcroft-Gault ...

8. Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas - Mayo Clinic

   - Hemoglobin ≥ 9.0 g/dL or > 5.6 mmol/L (transfusion is acceptable to meet this ;criterion) - Serum creatinine ≤ ULN or creatinine clearance ≥ 60 mL/min ...

9. To Compare the Efficacy and Safety of the HAV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis (HUMAXX) - Mayo Clinic

   * Previous vascular access location The ultimate decision of anatomic suitability belongs to the surgeon and/or the investigator. 5. Hemoglobin ≥ 7 g/dL and ...

10. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    Hemoglobin ≥ 9 g/dL;; Serum total bilirubin ≤ 1.5× upper limit of normal (ULN) (total bilirubin must be < 3 × ULN for patients with documented Gilbert's ...